ARKRAY, Inc. engages in the manufacture and sale of medical and surgical equipment. It develops products that focus on diabetes testing and urinalysis. It also provides the medical testing systems and functional food materials. The company was founded by Tadashi Doi on June 10, 1960 and is headquartered in Kyoto, Japan.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell signaling and the control of gene expression. The company is focused primarily of three main areas; inflammation, metabolic diseases and oncology. Tularik was founded by David Goeddel along with Steve McKnight and Robert Tjian in 1991. The company was acquired by Amgen for US$ 1.3 billion in 2004.

TCI GENE, Inc. engages in provision of health management services. Its products include genetic testing, nutritious supplements, skincare, and antiaging. The company was founded on July 13, 2011 and is headquartered in Taipei, Taiwan.

Shanghai Likang Pharmaceutical Technology Co. Ltd. is a Chinese private company located in Shanghai. The firm produces and distributes pharmaceutical drugs.

Morinaga & Co., Ltd. engages in the manufacture, purchase, and sale of confectioneries. It operates through the following business segments: Food Manufacturing, Food Merchandise and Restaurant, Real Estate and Services, and Others. The Food Manufacturing segment manufactures and distributes confectioneries, foodstuffs, frozen desserts, and health products. The Food Merchandise and Restaurant segment involves with the operation of restaurants. The Real Estate and Services segment deals with real estate business and operation of golf courses. The Others segment includes the manufacture and sale of research reagents. The company was founded by Taichiro Morinaga on August 15, 1899 and is headquartered in Tokyo, Japan.

Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland.

Shanghai Zhongyou Gene Technology Co., Ltd., established on 2008-01-17, Business scope includes general items:gene technology,biomedicine,Genetic Testing,Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),health technology,Technology development in the computer field,Technical Services,technical consulting,technology transfer;Daily necessities,electronic product,Stationery,handcrafted gift(Except for ivory and its products),Toy,clothing,sales of cosmetics.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

SolGent Co., Ltd. provides solutions for molecular biology, molecular diagnostics and genetics. Its business areas are Molecular Diagnosis, Molecular Biology and Genetic Analysis Service. The firm's Molecular Diagnosis business develops pathogen detection and human genotype kit and microbial screening, Molecular Biology research offers amplification, cloning, and biological reagents and the Genetic Analysis Service provides sequencing, genotyping, DNA fingerprinting, and microorganism identification service. The company was founded in 2000 and is headquartered in Daejeon, South Korea.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Offers medical biotechnology services

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (personalized medicine), assess a patient's risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriad's discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: "There is no more exciting story in medical science." Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics, Inc..

Zhongchuang Huanyu Biotechnology Co., Ltd., established on 2018-11-22, Business scope includes plant extraction and purification,Technology research and development of food additives,Production,Sales(The operating permit);Plant Extraction and Purification Technology,Equipment research and development,application,Service and Promotion,technical consulting;food,Processing and sales of health food(The operating permit).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianfang Innovation (Beijing) Information Technology Co., Ltd., established on 2011-08-15, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Medical Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Shanghai Jinfang Biotechnology Co., Ltd., established on 2010-03-29, Business scope includes biotechnology(except food,medicine,blood products)Technology development in the field,technical consulting,technology transfer,Technical Services,gene technology,Research and development of genetic testing technology and related reagents,Technical Services,Health Advisory(Do not engage in medical activities,psychological counseling),electronics,Instrument wholesale,retail. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Henan Xinshi Biotechnology Co., Ltd., established on 2019-12-09, Business scope includes plant extraction and purification,food additives,Technology research and development of preservatives,Production,Sales(The operating permit).Prepackaged Food Processing,Sales.Biotechnology R&D,Equipment research and development,application,Service and Promotion,technical consulting,Technology transfer and equipment sales.food,Processing and sales of health food(The operating permit).Import and export business of related products.

Shanghai Zhongyou Precision Medicine Technology Co., Ltd., established on 2012-03-31, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Security Consulting Services;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;internet sales(Except for products that require a license for sale);food sales(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)